免疫腫瘤學檢測市場：按產品、技術、適應症、應用、地區 - 規模、份額、展望、機會分析，2022-2028 年

免疫腫瘤學作為一種通過刺激人體免疫系統來治療癌症的新方法而備受關注。 這是對抗癌症的有力武器，因為它可以利用人體的天然防禦系統來抵抗感染。 它使用患者自身的免疫系統來檢測和破壞癌細胞。 免疫腫瘤學是抗癌藥物治療領域最有前途的研究領域之一。

市場動態

全球癌症負擔的增加、對開發新型癌症療法的更多關注、研發活動的增加以及免疫腫瘤學重要性的增加將導致預測期內全球免疫腫瘤學的增長。一些關鍵因素預計會推動生化分析市場的增長是：

例如，2021 年 4 月，羅氏宣布推出“Elecsys Anti-p53 免疫測定”，該產品支持對可用於診斷咽癌、腸癌和乳腺癌的抗 p53 抗體進行體外定量測量。。 此外，2019 年 4 月，Roche Diagnostics 將推出一種新的檢測方法 VENTANA HER2 Dual ISH DNA Probe Cocktail，用於識別乳腺癌和胃癌中的人類表皮生長因子受體 2 (HER2) 生物標誌物。

這項研究的主要特點

• 本報告對全球腫瘤免疫分析市場進行了深入分析，提供了以 2021 年為基準年的預測期 (2022-2028) 的市場規模和復合年增長率 (CAGR%)。I'我在這裡。
• 解釋了不同細分市場的潛在創收機會，並描述了針對該市場的有吸引力的投資建議矩陣。
• 它還提供了有關市場驅動因素、制約因素、機會、新產品發布或批准、市場趨勢、區域前景、主要參與者採用的競爭戰略等方面的重要見解。
• 它根據以下參數（包括公司亮點、產品組合、主要亮點、財務業績和戰略）介紹了全球免疫腫瘤學檢測市場的領先企業。
• 本研究涵蓋的主要公司包括 Charles River、Roche、llumina 和 Agilent Technologies, Inc. 等。
• 這份報告中的見解將使營銷人員和公司的高管能夠就未來的產品發布、類型升級、市場擴張和營銷策略做出明智的決策。
• 本研究報告面向該行業的各種利益相關者，包括投資者、供應商、產品製造商、分銷商、新進入者和金融分析師。
• 利益相關者可以通過用於分析全球免疫腫瘤學檢測市場的各種戰略矩陣來促進決策制定。

內容

第 1 章目的和先決條件

• 調查目的
• 先決條件
• 縮寫說明

第二章市場展望

• 報告內容
  • 市場定義和範圍
• 執行摘要
  • 市場概況：按產品分類
  • 市場概況：按技術分類
  • 市場概況：按指示
  • 市場概況：按應用分類
  • 市場概況：按地區
• 連貫機會圖 (COM)

第3章市場動態、規律及趨勢分析

• 市場動態
  • 全球癌症發病率上升
  • 缺乏熟練的專業人員
  • 增加研發 (R&D) 活動
• 影響分析
• 主要亮點
• 監管場景
• 產品發布/批准
• 害蟲分析
• 對 PORTER 的分析
• 合併/收購場景

第 4 章全球免疫腫瘤學檢測市場：冠狀病毒 (COVID-19) 大流行的影響

• COVID-19 的流行病學特徵
• 供應方和需求方分析
• 經濟影響

第 5 章全球免疫腫瘤學檢測產品市場，2017-2028

• 消耗品
• 軟件

第 6 章免疫腫瘤學檢測市場：按技術分類，2017-2028

• 免疫測定
• 聚合□鏈反應
• 下一代測序
• 流式細胞術
• 其他

第 7 章免疫腫瘤學檢測市場：按適應症分類，2017-2028

• 結腸癌
• 肺癌
• 黑色素瘤
• 膀胱癌
• 其他

第 8 章免疫腫瘤學檢測市場：按應用，2017-2028

• 臨床診斷劑
• 用於研究和開發

第 9 章免疫腫瘤學檢測市場：地區，2017-2028

• 北美
• 歐洲
• 亞太地區
• 拉丁美洲
• 中東和非洲
• 世界其他地方

第10章競爭格局

• Charles River
• Roche
• llumina
• Agilent Technologies, Inc.

第 11 章章節

• 調查方法介紹
• 關於出版商

Immuno-oncology is emerging as a novel approach to cancer treatment through the stimulation of the body's own immune system. It is a formidable weapon against cancer as it has the ability to harness the body's natural defenses against infection. It is method that tap into the patient's own immune system to detect and destroy cancer cells. Immuno-oncology is one of the most promising areas of research in the world of anti-cancer therapeutics.

Market Dynamics:

Increase in burden of cancer across the globe, rise in focus on the development of novel cancer treatments, increase in research and development (R&D) activities, and growing significance of immuno-oncology are some major factors expected to drive growth of the global immuno-oncology assays market over the forecast period.

For instance, in April 2021, Roche announced the launch of its Elecsys Anti-p53 immunoassay to boost in vitro quantitative determination of anti-p53 antibodies to help diagnose throat, bowel, and breast cancer. Moreover, in April 2019, Roche Diagnostics announced the launch of the new VENTANA HER2 Dual ISH DNA Probe Cocktail assay for identification of human epidermal growth factor receptor 2 (HER2) biomarker in breast and gastric cancers.

Key features of the study:

• This report provides in-depth analysis of the global immuno-oncology assays market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global immuno-oncology assays market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Charles River, Roche, llumina, and Agilent Technologies, Inc., among others.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global immuno-oncology assays market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global immuno-oncology assays market.

Detailed Segmentation:

• Global Immuno-Oncology Assays Market By Product:
  • Consumables
  • Software
• Global Immuno-Oncology Assays Market By Technology:
  • Immunoassay
  • PCR
  • NGS
  • Flow Cytometry
  • Others
• Global Immuno-Oncology Assays Market By Indication:
  • Colorectal Cancer
  • Lung Cancer
  • Melanoma
  • Bladder Cancer
  • Others
• Global Immuno-Oncology Assays Market By Application:
  • Clinical Diagnostics
  • Research and Development
• Global Immuno-Oncology Assays Market By Region:
  • North America
  • Europe
  • Asia-Pacific
  • Middle East and Africa
  • South America
• Company Profiles:
  • Charles River
  • Roche
  • Llumina
  • Agilent Technologies, Inc.

Table of Contents:

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Product
  • Market Snapshot, By Technology
  • Market Snapshot, By Indication
  • Market Snapshot, By Application
  • Market Snapshot, By Geography
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Rise in burden of cancer across the globe
  • Dearth of skilled professionals
  • Increase in research and development (R&D) activities
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product launch/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Global Immuno-Oncology Assays Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Immuno-Oncology Assays Market, By Product, 2017-2028, (US$ Mn)

• Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
• Consumables
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
• Software
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)

6. Immuno-Oncology Assays Market, By Technology, 2017-2028, (US$ Mn)

• Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
• Immunoassay
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
• PCR
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
• NGS
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
• Flow Cytometry
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)

7. Immuno-Oncology Assays Market, By Indication, 2017-2028, (US$ Mn)

• Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
• Colorectal Cancer
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
• Lung Cancer
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
• Melanoma
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
• Bladder Cancer
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)

8. Immuno-Oncology Assays Market, By Application, 2017-2028, (US$ Mn)

• Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
• Clinical Diagnostics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
• Research and Development
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)

9. Immuno-Oncology Assays Market, By Geography, 2017-2028, (US$ Mn)

• Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
• Middle East and Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
• Rest of World
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)

10. Competitive Landscape

• Charles River
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Roche
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• llumina
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Agilent Technologies, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Analyst Views

11. Section

• Research Methodology
• About us